Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04512144 · ClinicalTrials.gov registry record · NA
Mindfulness in Endometrial and Cervical Cancer
A NA study of Endometrial Cancer and Cervical Cancer, sponsored by St. Louis University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04512144: Recruiting NA study of Endometrial Cancer and Cervical Cancer, sponsored by St. Louis University.
NCT04512144 is a NA study of Endometrial Cancer and Cervical Cancer that is actively recruiting participants, run by St. Louis University. The registered enrollment target is 120 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04512144, a NA study of Endometrial Cancer and Cervical Cancer, is actively recruiting participants, sponsored by St. Louis University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.
Primary Outcome
The amount of opiates used during the acute (30 day) recovery after surgery for endometrial cancer or acute treatment with chemoradiation for cervical cancer will be recorded.
Conditions Studied
Interventions
- BEHAVIORAL Headspace Smartphone Application
Study Locations (1)
Missouri
- Saint Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-07-25 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT04512144 shows while recruiting
NCT04512144 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (77% lower).
The record links to 5 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Headspace Smartphone Application is the first listed.
NCT04512144 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04512144 about?
NCT04512144 is a clinical study titled "Mindfulness in Endometrial and Cervical Cancer". Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.
What is the current status of trial NCT04512144?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2020-07-25. Estimated completion is 2026-07-30.
What conditions does trial NCT04512144 study?
This clinical trial studies the following conditions: Endometrial Cancer, Cervical Cancer, Quality of Life, Opioid Use, Gynecologic Cancer.
What interventions are being tested in trial NCT04512144?
The interventions under investigation include: Headspace Smartphone Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT04512144?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04512144 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04512144's enrollment target sits among peer trials
120 85th of 181 higher than 96 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI